$
Federal Contract Award
Amgen USA INC
Department of Health and Human Services · January 12, 2024 · FY2024
75A50118F33003Set-aside not reportedNAICS 325414
Obligated
$657,406
Contract details
- Award ID
- CONT_AWD_75A50118F33003_7505_HHSO100201300006I_7505
- PIID
- 75A50118F33003
- Period of performance
- September 19, 2018 → March 16, 2024
- Place of performance
- NEWBURY PARK, CA, USA
- Set-aside
- Not reported
- Pricing type
- FIRM FIXED PRICE
- PSC
- AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
- NAICS
- 325414 — BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING
Scope
RTOR NUMBER: RTOR-CSF-0004 MAINTENANCE OF PREVIOUSLY PURCHASED COLONY STIMULATING FACTOR(S) (G- OR GM-CSF) FOR MITIGATION OF NEUTROPENIA ARISING FROM EXPOSURE TO IONIZING RADIATION
Parent vehicle (IDV)
Amgen USA INC
UEI Y6NEW42XK544
This award was placed as a task/delivery order under a larger contract vehicle.
Awarding agency
Department of Health and Human Services →- Sub-agency
- Office of Assistant Secretary for Preparedness and Response
- Office
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funding agency
- Department of Health and Human Services
- Funding office
- BARDA - ASPR / DAAPPO / BARDA DCMA
See every contract Amgen USA INC has won
Full contracting history, year-over-year trends, subaward graph, and recompete alerts.
View Amgen USA INC profile →